{"id":"W4306923381","doi":"10.3389/fneur.2022.846126","title":"Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia","year":2022,"lang":"en","type":"article","venue":"Frontiers in Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Sun Pharma; Voyager Therapeutics; Supernus Pharmaceuticals; F. Hoffmann-La Roche; Cerecor; Britannia Pharmaceuticals; Neurocrine Biosciences; Acorda Therapeutics; Parkinson Study Group; H. Lundbeck A/S; Sunovion; Adamas Pharmaceuticals; Parkinson's Foundation; Amneal Pharmaceuticals; Biogen; Northwestern University; University of Pennsylvania; Genentech; ACADIA Pharmaceuticals; Ipsen; Jazz Pharmaceuticals; Teva Pharmaceutical Industries; US WorldMeds; Allergan; AstraZeneca; Eli Lilly and Company; Axial Biotherapeutics; Sanofi; Revance; Michael J. Fox Foundation for Parkinson's Research","keywords":"Dyskinesia; Rating scale; Parkinson's disease; Placebo; Medicine; Clinical Global Impression; Physical therapy; Psychology; Disease; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002679311,0.0004306269,0.001049135,0.0004412111,0.0003113042,0.0005061721,0.0002823287,0.0004484703,0.0009282592],"category_scores_gemma":[0.004024833,0.0001919372,0.0006942608,0.0004539668,0.0002411024,0.0004798501,0.0004032785,0.0006346557,0.0001775996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002705297,"about_ca_system_score_gemma":0.00022493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006997828,"about_ca_topic_score_gemma":0.001777006,"domain_scores_codex":[0.9987047,0.0006036478,0.0001604038,0.0002232647,0.0002209317,0.00008707018],"domain_scores_gemma":[0.9973649,0.0008254298,0.001126088,0.00008843934,0.0002504397,0.0003447134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01438996,0.0006573104,0.9619197,0.0001971048,0.0004696656,0.0001194358,0.0002177409,0.0004044841,0.001471125,0.00004114516,0.0005639721,0.01954846],"study_design_scores_gemma":[0.001097107,0.006673748,0.9906105,0.00002686736,0.0001603518,0.0001880687,0.00006560247,0.0006064342,0.0002073251,0.0000342334,0.0003158823,0.00001376822],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970536,0.0009822632,0.0001530159,0.00004841557,0.00001672073,0.0001904151,0.0004082122,0.000008646988,0.001138617],"genre_scores_gemma":[0.9988398,0.0001631282,0.0002665041,0.00004541416,0.00001654884,0.000114382,0.0004274476,0.000001419984,0.0001253504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002679311,"threshold_uncertainty_score":0.01416975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01403652447291229,"score_gpt":0.2344534492212566,"score_spread":0.2204169247483443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}